Comparison of the Anabolic Effects of Synthetic Parathyroid Hormone-Related Protein (PTHrP) 1–34 and PTH 1–34 on Bone in Rats*
Authors:
- J. M. HockJHJ. M. Hock
- J. FonsecaJFJ. Fonseca
- M. Gunness HeyMHM. Gunness Hey
- B. E. KempBKB. E. Kemp
- T. J. MartinTMT. J. Martin
- 1 October 1989
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 125 (4) , 2022-2027
Abstract
The objective of this study was to determine whether intermittent synthetic human PTH-related protein (PTHrP 1-34) will mimic the anabolic effect of PTH and increase bone mass in rats. Dose response experiments were done on young, male Sprague-Dawley rats given sc vehicle, human (h) PTH (1-34) at 8 micrograms/100 g or PTHrP (1-34) at 1-32 micrograms/100 g daily for 12 days or 26 days. On the last day, 3 h after injections, rats were killed and serum, femurs, and tibias harvested. Trabecular and cortical bone of distal half femurs were analyzed for calcium (Ca) and hydroxyproline content and dry weight. Tibia metaphyseal bone was analyzed using conventional histomorphometry techniques. Our results showed that low doses of PTHrP (1-34) did not increase bone mass or bone forming surfaces. After 12 days, PTH, at 8 micrograms/100 g, increased trabecular Ca, dry weight, and hydroxyproline by approximately 19%, 36%, and 53%, respectively, while the bone mass of PTHrP-treated rats was comparable to vehicle-treated rats. PTHrP at a higher dose of 32 micrograms/100 g, increased trabecular bone mass by 30-37%, compared to the 43-48% increase induced by PTH at 8 micrograms/100 g after 12 days. When treatment was extended to 26 days, PTHrP, at 16 micrograms/100 g, increased trabecular bone mass by 24-36%, respectively, compared to the 43-61% increase induced by PTH at 8 micrograms/100 g. Unlike PTH, which increased cortical bone mass by 15-25%, PTHrP increased cortical bone mass only at the highest dose tested, 32 micrograms/100 g. Bone forming surfaces but not bone apposition rate were increased by PTH and PTHrP while resorption measures remained comparable to control values. Although serum Ca and Pi remained in the physiological range for all rats, the values for PTHrP-treated rats were consistently higher. In conclusion, PTHrP (1-34) was less potent and less effective than PTH (1-34) in inducing an anabolic response in bone in vivo.Keywords
This publication has 17 references indexed in Scilit:
- Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy.Proceedings of the National Academy of Sciences, 1988
- Parathyroid Hormone-Related Protein of Malignancy: Active Synthetic FragmentsScience, 1987
- Similarity of Synthetic Peptide from Human Tumor to Parathyroid Hormone in Vivo and in VitroScience, 1987
- A Parathyroid Hormone-Related Protein Implicated in Malignant Hypercalcemia: Cloning and ExpressionScience, 1987
- Parathyroid hormone-related protein purified from a human lung cancer cell line.Proceedings of the National Academy of Sciences, 1987
- Increased trabecular bone mass in rats treated with human synthetic parathyroid hormoneMetabolic Bone Disease and Related Research, 1984
- Quantitative Bone Histology in the Hypercalcemia of Malignant Disease*The Journal of Clinical Endocrinology & Metabolism, 1982
- Quantitative Bone Histomorphometry in Humoral Hypercalcemia of Malignancy: Uncoupling of Bone Cell Activity*The Journal of Clinical Endocrinology & Metabolism, 1982
- Parathyroid Hormone Stimulates the Bone Apposition Rate Independently of Its Resorptive Action: Differential Effects of Intermittent and Continuous Administration*Endocrinology, 1982
- Variations produced in bones of growing rats by parathyroid extractsJournal of Anatomy, 1938